肥胖症是否迎来了新希望？ - Suppr

Suppr

超能文献

Is new hope on the horizon for obesity?

作者信息

Bray George A

机构信息

Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA.

出版信息

Lancet. 2008 Nov 29;372(9653):1859-1860. doi: 10.1016/S0140-6736(08)61792-4.

DOI:10.1016/S0140-6736(08)61792-4

PMID:19041787

Abstract

摘要

相似文献

Is new hope on the horizon for obesity?

Lancet. 2008 Nov 29;372(9653):1859-1860. doi: 10.1016/S0140-6736(08)61792-4.

[The pharmacological treatment of obesity: past, present and future].

Orv Hetil. 2012 Mar 11;153(10):363-73. doi: 10.1556/OH.2012.29317.

Comparative efficiency and safety of pharmacological approaches to the management of obesity.

Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S349-54. doi: 10.2337/dc11-s255.

[Pharmacotherapy for weight loss in patients with type 2 diabetes].

Ugeskr Laeger. 2007 Aug 13;169(33):2619-22.

[New drugs for the treatment of obesity].

Duodecim. 1999;115(20):2191, 2193-4.

The war against obesity: attacking a new front.

Am J Clin Nutr. 1999 Jun;69(6):1061-3. doi: 10.1093/ajcn/69.6.1061.

[Is there a future for medical treatment of obesity?].

Ugeskr Laeger. 2009 Oct 5;171(41):2973.

Tesofensine and weight loss.

Lancet. 2009 Feb 28;373(9665):719; author reply 720. doi: 10.1016/S0140-6736(09)60433-5.

Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial.

Lancet. 2008 Nov 29;372(9653):1906-1913. doi: 10.1016/S0140-6736(08)61525-1. Epub 2008 Oct 22.

[The effect of tesofensine on body weight and body composition in obese subjects--secondary publication].

Ugeskr Laeger. 2009 Oct 5;171(41):2974-7.

引用本文的文献

Combinations of drugs in the Treatment of Obesity.

Pharmaceuticals (Basel). 2010 Jul 27;3(8):2398-2415. doi: 10.3390/ph3082398.

Peroral endoscopic reduction of dilated gastrojejunal anastomosis after bariatric surgery: Techniques and efficacy.

World J Gastrointest Endosc. 2016 Feb 25;8(4):239-43. doi: 10.4253/wjge.v8.i4.239.

Outcomes of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding.

World J Gastroenterol. 2013 Sep 28;19(36):6035-43. doi: 10.3748/wjg.v19.i36.6035.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Is new hope on the horizon for obesity?

Lancet. 2008 Nov 29;372(9653):1859-1860. doi: 10.1016/S0140-6736(08)61792-4.

[The pharmacological treatment of obesity: past, present and future].

Orv Hetil. 2012 Mar 11;153(10):363-73. doi: 10.1556/OH.2012.29317.

Comparative efficiency and safety of pharmacological approaches to the management of obesity.

Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S349-54. doi: 10.2337/dc11-s255.

[Pharmacotherapy for weight loss in patients with type 2 diabetes].

Ugeskr Laeger. 2007 Aug 13;169(33):2619-22.

[New drugs for the treatment of obesity].

Duodecim. 1999;115(20):2191, 2193-4.

The war against obesity: attacking a new front.

Am J Clin Nutr. 1999 Jun;69(6):1061-3. doi: 10.1093/ajcn/69.6.1061.

[Is there a future for medical treatment of obesity?].

Ugeskr Laeger. 2009 Oct 5;171(41):2973.

Tesofensine and weight loss.

Lancet. 2009 Feb 28;373(9665):719; author reply 720. doi: 10.1016/S0140-6736(09)60433-5.

Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial.

Lancet. 2008 Nov 29;372(9653):1906-1913. doi: 10.1016/S0140-6736(08)61525-1. Epub 2008 Oct 22.

[The effect of tesofensine on body weight and body composition in obese subjects--secondary publication].

Ugeskr Laeger. 2009 Oct 5;171(41):2974-7.

引用本文的文献

Combinations of drugs in the Treatment of Obesity.

Pharmaceuticals (Basel). 2010 Jul 27;3(8):2398-2415. doi: 10.3390/ph3082398.

Peroral endoscopic reduction of dilated gastrojejunal anastomosis after bariatric surgery: Techniques and efficacy.

World J Gastrointest Endosc. 2016 Feb 25;8(4):239-43. doi: 10.4253/wjge.v8.i4.239.

Outcomes of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding.

World J Gastroenterol. 2013 Sep 28;19(36):6035-43. doi: 10.3748/wjg.v19.i36.6035.